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ABSTRACT 
 
Low Dose Radiation Interactions with the  
Transformation Growth Factor (TGF)-beta Pathway.  (August 2007) 
Amy Jesse Maslowski, B.S., College of Charleston 
Chair of Advisory Committee: Dr. John R. Ford 
 
A major limiting factor for long-term, deep-space missions is the radiation dose to 
astronauts.  Because the dose to the astronauts is a mixed field of low- and high-LET 
radiation, there is a need to understand the effects of both radiation types on whole 
tissue; however, there are limited published data on the effects of high-LET (linear-
energy-transfer) radiation on tissue.  Thus, we designed a perfusion chamber system for 
rat trachea in order to mimic in vivo respiratory tissue.  We successfully maintained the 
perfused tracheal tissue ex vivo in a healthy and viable condition for up to three days.  In 
addition, this project studied the effects of high-LET Fe particles on the overall 
transformation growth factor (TGF)-beta response after TGF-beta inactivation and 
compared the results to the TGF-beta response post x-ray irradiation.  It was found that a 
TGF-beta response could be measured in the perfused tracheal tissue, for x-ray and Fe 
particle irradiations, despite the high autofluorescent background intrinsic to tissue.  
However, after comparing the TGF-beta response of x-ray irradiation to High-Z-High-
energy (HZE) irradiation, there was not a significant difference in radiation types.  The 
TGF-beta response in x-ray and HZE irradiated perfusion chambers was also measured 
over time post irradiation.  It was found that for 6 hour and 8 hour post irradiation, the 
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TGF-beta response was higher for lower doses of radiation than for higher doses.  This is 
in contrast to the 0 hour fixation which found the TGF-beta response to increase with 
increased dose.  The inverse relationship found for 6 hour and 8 hour fixation times may 
indicate a threshold response for TGF-beta response; i.e., for low doses, a threshold of 
dose must be reached for an immediate TGF-beta response, otherwise the tissue 
responds more slowly to the irradiation damage.  This result was unexpected and will 
require further investigation to determine if the threshold can be determined for the 250 
kVp x-rays and 1 Gev Fe particles.  
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NOMENCLATURE 
 
ECM Extracellular Matrix 
GCR Galactic Cosmic Ray 
HZE High-Z-High-Energy 
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CHAPTER I* 
INTRODUCTION 
 
Since space travel began, man has faced the challenges of leaving the earth’s atmosphere 
to reach orbit and travel beyond.  The environment a flight crew faces is drastically 
different than the terrestrial environment.  On the earth’s surface, biological processes 
are well adapted to the gravity of earth and are protected from the types and quantities of 
radiation found in space by earth’s atmosphere and its intrinsic magnetic field.  
Microgravity and increased background radiation levels are known to cause specific 
risks for astronauts including muscle atrophy and calcium loss.  Radiation risks will 
become serious problems for longer future missions that travel deeper into space.  The 
future of space exploration depends on finding a solution to these challenges.  
 
The most significant risk of deep and prolonged space travel identified thus far is 
calcium loss.  Whole body calcium loss was found to reduce bone mineral density in the 
tibia, greater trochanter, femoral neck, and lumbar vertebrae by averages of 2.8%, 8.2%, 
5.0%, and 6.2%, respectively, for seven astronauts who stayed on the Mir space station 
for four to six months.  Skylab data showed the body loses 200 to 300 mg/d of calcium 
(1).  Countermeasures are being tested in an effort to ameliorate the bone loss caused by 
extended flight times; however, nothing has been found to correct this loss.   
 
                                                 
 This dissertation follows the style of Radiation Research. 
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More significantly, the reduction in bone density is indicative of a change in cellular 
processes and could have an effect on how the cell responds to DNA damage.  Studies 
have addressed microgravity effects on a cell’s response to ionizing radiation and have 
found no conclusive results.  Early experiments found human leukocytes flown in space 
do have increased levels of chromosome deletions as compared to ground-level 
irradiations (2).  However, these results could not be confirmed with subsequent 
experiments (3).  Moreover, theoretical analysis of gravity’s effects on DNA postulate 
that it should be negligible for structures smaller than the nucleus (4).  Kiefer and Pross 
calculated that the gravitational energy would be orders of magnitude lower than the 
thermal energy of molecules due to gravity’s dependence on mass.  Current experiments 
have made only one thing clear: the biological responses to High-Z-High-Energy (HZE) 
particles in reduced gravity are not yet completely understood.   Hence, focusing 
research on HZE biological effects for ground-level experiments may help correlate how 
microgravity changes the biological response to irradiations.   
 
One of the most significant health risks of future space travel is exposure to the harsh 
radiation field beyond the protection of the earth’s Van Allen belts.  The crew on such 
missions will be exposed to a continuous spectrum of background galactic cosmic rays 
(GCR) in addition to intermittent energetic solar particle events (SPE).  Both sources 
contribute to radiation risks to flight crews and each has unique properties and 
interactions with biological systems.  The sources of GCR have yet to be positively 
identified, but are most probably supernova remnants accelerated by magnetic fields and 
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result in a generally isotropic field of high-energy charged particles.  Of the charged 
particle spectrum, 98% are protons and heavy ions, and two percent are electrons and 
positrons ranging in energy from 10 MeV/n to 10 GeV/n (5).  The particles that would 
contribute the most to the equivalent dose to astronauts in this spectrum are hydrogen, 
helium, carbon, neon, oxygen, silicon and iron.   SPE are also a significant contributor to 
the dose to astronauts and usually occur at solar maximum; however there is no reliable 
method for predicting when and at what magnitude an SPE will occur.  The SPE fluence 
can be greater than 1010 protons/cm2 with energies greater than 10 MeV.  In addition to 
large proton fluence, an SPE may consist of alpha particles and heavier nuclei; however, 
there is a shortage of data so risks due to SPE are difficult to determine.   These two 
spectra are the major sources for equivalent dose to the crew during space flight, but 
since the spectra are not well known, their interactions in tissue and resulting estimation 
of equivalent doses are uncertain at present.   
 
Radiation Effects 
Ionizing radiation causes damage to cells and its DNA and can result in the formation of 
micronuclei and the induction of bystander effects.  While much research has addressed 
these effects on biological systems, the effects of HZE particles are little studied and 
poorly understood.  In order to better understand these effects, the interaction of HZE 
particles with cells and their effect is the present interest of this study.    
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The radiation environment in low earth orbit (LEO) consists of high energy protons, 
HZE particles and secondary radiation produced as a result of interactions with 
spaceship walls and tissue.  Despite their low frequency, HZE particles are of great 
importance to risk because of their high ionization potential and their large contribution 
to equivalent dose.  Unlike low-linear energy transfer (LET) radiation which has a 
tortuous path through tissue and spatially distributed energy deposition, HZE particles 
are known to deposit most of their energy localized along the path of the primary particle 
resulting in a dense ionization path (see Fig. 1). 
 
 
FIG. 1.  Three human fibroblast nuclei irradiated with 2 Gy of γ-rays (A), 0.5 Gy of 54 
keV/µm silicon ions (B) and 0.5 Gy of 176 keV/µm iron ions (C) and stained for γ-
H2AX clusters.  Each green spot is thought to represent a DNA double strand break (6). 
 
 
The dense ionization caused by an HZE particle is due to its charge.  Patterns of damage 
to DNA and mechanisms of its repair are different than for low-LET radiation (7-10).  
Although the creation of double strand breaks (DSBs) by high-LET radiation has been 
found to be a linear function of dose (11-13), it has been shown that an increased number 
of double strand breaks (DSBs) caused by high-LET radiation do not rejoin as easily in 
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comparison with low-LET radiation (14).  There are significant gaps in the elucidation 
of a cell’s response to high-LET radiation, and there is currently little human data 
examining these kinds of exposures.  Current research in animals, from a limited number 
of studies, shows that HZE particles have an increased carcinogenic effect as compared 
to low-LET radiation (15-17).  Further study is necessary to better understand the 
interactions of high-LET HZE particles and the resulting effects on cellular function.       
 
Biological Response to Radiation 
Radiation biology is focused on determining the nature of interactions of radiation with 
cells and the probability for relevant biological effects. This is fundamental for 
improving the reliability of health risk estimates at low doses.  Several characteristics of 
the radiation and the target system are likely to influence the magnitude and frequency 
of variation in responses of individual cells.  The obvious properties of the radiation are 
the energy deposited, mass and velocity of the charged particle, the spatial distribution of 
the energy deposited, and the temporal distribution of events.  In experimental 
conditions, these variables can be characterized and defined; the biological target is 
usually the most difficult part of the experimental system to identify and control.  
 
The relevant characteristics of the target system include anything that may influence the 
amount of energy deposited; conditions (such as oxygen concentration) that influence 
the consequences of energy deposition, and factors (such as cell-to-cell contact and 
extracellular matrix structure and the cell culture environment) that all influence the 
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communication of information and materials between cells.  For example, the substrate, 
and the cell population density influence the geometry of the cell (how flattened it is), 
which in turn influences the energy deposited by a particle with a given stopping power.  
This may also influence the proximity of sensitive targets within the cell and possibly 
even the effectiveness of some repair processes.  Cell culture is a good example of an 
environment in which cells will take on a more flattened geometry.  Cells in this 
environment attach to the substrate, a cell culture flask, divide, and spread evenly across 
the flask.  At low densities these cells have no contact inhibition and their growth is not 
directed by other cells.  Because of this, the cells in culture must be closely monitored 
and passed, or split, into multiple other flasks when they have covered approximately 
85% of the substrate surface.  It is due to this constant growth and spreading that leads to 
a more flattened geometry.  In contrast, cells in organized environments, such as tissue, 
are contact inhibited and their growth is directed by other cells.  Therefore, normal cells 
have a defined growth cycle.  In most tissues, this results in a much less flattened 
geometry in comparison with similar cell types cultured in flasks.   
 
The number of cells per unit area on the dish clearly influences the opportunity for gap 
junction communication between cells, but it also may influence the nutritional status of 
the cell and signals relevant to cell cycle regulation.  Experiments with monolayer cell 
cultures cannot fully represent the effects that may occur in normal tissues.   
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Normal tissue is a combination of extracellular matrix, immune system, vasculature, 
multiple cell types, etc., and each factor impacts a cell’s response to stimuli.  For 
example, the media used in cell culture systems is thought to sufficiently nourish the 
cells; however, there is not a complete understanding of what a cell needs to fully 
function and mimic an in vivo condition.  In fact, media components, such as fetal 
bovine serum, cannot be completely characterized; hence, there is no assurance that a 
cell is receiving the same nutrition it would receive in vivo.  Thus, the further from a 
normal tissue a cell is cultured, the more difficult it is to attribute its response solely to 
the stimulus.  Organ cultures and reconstituted tissues are currently the best system to 
simulate the normal cell environment as closely as possible, and yet provide the 
reproducibility and flexibility needed to make it possible to interpret the results of 
radiation exposure.   
 
Cell Culture Model 
Cell culture models have been central in understanding the interaction of radiation and 
individual cells.  The primary advantages of using cell culture models for radiation 
experiments are that they are easily manipulated and isolated.  These models are 
important when studying complex intracellular pathways because they can be examined 
without disturbance by signals from other cell types or the extracellular matrix.  In 
addition to being easily manipulated and isolated, irradiations are more reproducible 
with cell culture models.  Microbeam experiments are very useful in radiation response 
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studies because the ease of targeting one cell in an environment of a larger number of 
adjacent cells.   
 
The bystander effect (i.e., the response of neighboring, unirradiated cells after a single 
cell irradiation) is often studied using microbeams and cell cultures.  There is evidence 
that some members of an irradiated population alter their levels of repair related proteins 
(18), and change their DNA metabolism (19-21) even though they cannot have been 
directly hit by an ionizing particle.  This effect has become important as it may imply, 
though equivocally, that a lower dose of radiation can cause an increased response 
compared to the one-hit, linear no-threshold model used to estimate rates of 
carcinogenesis and in setting dose limits.  The bystander response has been seen in 
multiple cell culture systems (22-24); however it has not been demonstrated 
categorically in vivo.    
 
These confounding and equivocal findings demonstrate the shortcomings and 
disadvantages in using an in vitro system.  There are two primary disadvantages of using 
in vitro systems. First, the cells used are often immortal, or they do not senesce.  Primary 
cells, or cells cultured directly from tissue, are the most similar to cells found in vivo, but 
they will senesce after a few divisions making them difficult to culture.  Immortalized 
cells seem to have some problems with growth control but maintain contact inhibition 
and anchorage dependency, both qualities of a normal cell type.  This is important for in 
vitro studies because immortalized cells are easier to culture and make it easier to study 
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long-term genetic effects of radiation.   Immortal cells, however, are rarely seen in vivo 
and are thought to be limited to stem cells.  The second disadvantage of cell culture 
systems is that the cell is isolated from its normal microenvironment.  A precarcinogenic 
phenotype seen in cells may never be seen in tissue because the surrounding cells and 
extracellular matrix affect the cellular response.  Cells are stimulated to divide, 
differentiate, or self destruct depending on signals from neighboring cells and the 
extracellular matrix.  This in vitro characteristic removes variables that interfere with a 
single cell’s response, however these variables can have a significant impact on a cell’s 
natural response to stimuli.  Underlying most simple cell culture models is the 
assumption that the irradiated response in a monolayer of homogenous cells is the same 
response that would be measured in a complicated tissue system with multiple cell types 
and an extracellular matrix.  As a result, cell culture models downplay the importance of 
interaction with the microenvironment to the overall response of cells. 
   
Respiratory Cells 
The tracheo-bronchial epithelium covers less than 1% of the lung surface exposed to the 
atmosphere but gives rise to approximately 90% of all primary lung tumors (25).  The 
epithelium is a pseudo-stratified, differentiated epithelium characterized by basal, 
secretory and ciliated cells (see Fig. 2).  Basal cells are small cells adjacent to the 
basement membrane and do not reach apical contact with the lumen.  Traditionally, these  
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FIG. 2.  A rat trachea with the secretory, basal and ciliated cells labeled. 
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cells are considered the stem cells of the epithelium and have been found to generate 
secretory and ciliated cells in rabbit trachea (26).  Studies have also shown that less than 
1% of airway epithelial cells are proliferating at any time and cycling cells are 
predominantly located near the basement membrane (27, 28).   
 
In the trachea epithelium, secretory cells are tall, columnar cells which have apical 
contact with the lumen and are characterized by numerous secretory granules.  Secretory 
cells are also able to differentiate.  Following epithelial injury in hamsters, studies show 
that the major proliferative response at the wound edge is by the secretory cells (29).  
Basal cells and secretory cells are both able to differentiate, but their role in the repair of 
the trachea epithelium is not clearly understood.  Ciliated cells also have apical contact 
with the lumen and are instrumental in moving mucus upward through the respiratory 
track.  Ciliated cells, however, are thought to be terminally differentiated and unable to 
divide.  
 
The complicated coordination of each cell type forms the tracheal epithelium and 
provides the primary line of defense against toxic inhalants.  Most particles are 
efficiently removed by the cilia without harming the trachea; however, there are 
environmental factors that can quickly cause extensive damage to the sensitive epithelial 
layer before removal.  Damaging factors include cigarette smoke, smog, toxic chemicals, 
radon exposure, etc.  While cigarette smoking is the number one cause of lung cancer, 
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radon exposure has been estimated to be the leading cause of lung cancer in non-
smokers.   
 
Rn-222 is a naturally occurring radioactive gas found in varying concentrations 
throughout the United States.  The gas exhausts from the soil and can accumulate in 
poorly ventilated homes or in ground water.  Rn-222 is considered a hazard to lung 
tissue because it emits a high energy, 5.6 MeV, alpha particle.  The alpha particle will 
deposit its energy in a short distance and cause localized damage to lung tissue.  This 
damage, delivered chronically over many years, leads to fibrosis. Damage is accelerated 
if paired with another damaging factor (cigarette smoking) and can lead to lung cancer.  
Epithelial lung tissue, its sensitivity to damage and its role as a primary barrier in 
fending off pollutants (including ionizing radiation), makes it structure and cellular 
components an important model for studying radiation injury.   
 
TGF-beta 
TGF-beta is a signaling transducer stored extracellularly in its latent form and is thought 
to provide a reservoir for future use by preserving its inactivity through attachment to 
extracellular components (30).  TGF-beta is secreted in its latent complex in two forms; 
the first form, small latent complex, is a dimer of the TGF-beta homodimer and the 
latent associated peptide (LAP); the second form, large latent complex, contains a third 
component, the latent TGF-beta binding protein (LTBP).  Each complex is attached to a 
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proteoglycan, decorin or betaglycan, and is attached to the extracellular matrix or the cell 
surface, respectively.  This proteoglycan binding preserves the inactivation of TGF-beta 
(see Fig. 3).   
 
Activation of TGF-beta requires LAP to be cleaved from the TGF-beta homodimer.  Once 
activated, TGF-beta attaches to cell surface receptor TGF-beta type II which dimerizes with 
TGF-beta type I receptor, resulting in the initiation of the TGF-beta pathway (31).  The 
initiation of this pathway causes a cascade of intracellular events.  Smads, latent gene 
regulatory proteins, are phosphorylated by the activated TGF-beta receptor; in this case, 
Smad2 or Smad3.  This receptor-activated Smad disassociates with the receptor and binds 
to Smad4 to make a complex.  This complex moves through the cell to the nucleus and 
activates a target gene.  The activation of the TGF-beta pathway has three major roles 
within a cell: immunosuppression, deposition of extracellular matrix components and 
epithelial cell growth inhibition (32).  TGF-beta studies have also characterized its role in 
radiation-induced fibrosis and carcinogenesis (33-36).  
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FIG. 3.  TGF-beta is a coordination of intra and extracellular processes. 
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Fibrosis is characterized by the disorganization of the extracellular matrix and is caused 
by over response of the tissue to injury.  Normally, a tissue will respond to injury 
through activation of mesenchymal fibroblasts, production of extracellular matrix 
components, and an organized deposition of these components (33).  Feedback 
mechanisms then downregulate this response and cease the production and deposition of 
the extracellular matrix components.  Fibrotic disease is the loss of regulation in this 
balanced response to injury and can lead to excessive production and deposition of 
extracellular matrix components, excessive tissue contraction, and the eventual loss of 
tissue function.  Currently, there is no effective therapy for the disease and patients often 
must resort to organ transplantation.  Examples of fibrotic diseases include liver 
cirrhosis, idiopathic pulmonary fibrosis, arteriosclerosis, and rheumatoid arthritis.  In 
addition to these diseases, fibrosis is observed to be a sequel to radiation therapy.  
Feedback mechanisms are being investigated in order to understand what causes the over 
response to occur.  TGF-beta, a profibrotic protein, has been shown to be a precursor to 
fibrosis (33-36).   
 
Inhibiting TGF-beta activity has been shown to affect the composition of the 
extracellular matrix and play a significant role in fibrosis induction in the lungs (37, 38) 
and also affect how a cell responds to radiation (39).  Because of its role in fibrosis, 
TGF-beta has been proposed to play a critical role in tissue repair after radiation injury.  
Specifically, Ehrhart, et al. found that blocking TGF-beta receptors with neutralizing 
antibodies reduced the collagen III immunoreactivity in the adipose stroma after 5 Gy 
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whole-body irradiation of mice (39).  Xavier, et al. also found that the inhibition of the 
TGF-beta pathway results in a resistance to high dose, 35 to 45 Gy, hind leg radiation 
exposure and fibrosis formation in mice (40).  TGF-beta clearly plays a role in collagen 
production after irradiation, but its role may not be limited to fibrosis.  Studies have also 
found that preneoplastic transformation is influenced by the concentration of TGF-beta 
in one model system (41, 42) and TGF-beta has been implicated as a possible mediator 
of some reported bystander effects (15, 43).  To what extent TGF-beta affects a cell’s 
function may be unknown, however, its role in fibrotic disease is known to be significant 
and is a focus of this study.  
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CHAPTER II 
BIOLOGICAL ASPECTS OF MODEL DESIGN* 
 
Currently, most radiation biology research, particularly high-Z and energy (HZE) 
experiments, utilizes cell culture models.  These cell culture models are a 2-D model 
consisting of a monolayer of immortalized cells cultured in a cell culture flask.  There 
are examples of cells that are maintained in a 3-D environment because their growth 
does not require attachment to a matrix; though, the limitations addressed here for the 2-
D model are also applicable to contact inhibited cells.  The 2-D model has significant 
advantages for certain experiments (microbeam irradiations, intra-cell signaling 
pathways, those that require real-time observations, and controlling growth factors and 
nutrition); however most neglect the importance of the extracellular matrix and other 
supporting cell types on the response of a cell to stimuli.  It is known that signal 
transduction, shape, and differentiation of a cell may be controlled by its 3-D 
environment (44).  Also, cells used in 2-D experiments are often from a single cloned 
cell line and cannot perform all functions of a complete organ or tissue.  Moreover, 
signaling between multiple cell types does not occur in a 2-D environment.  These 
influences are significant, especially when trying to extrapolate monolayer cell results 
and in vivo environments.   
 
                                                 
*
 Portions of this chapter are reprinted with permission from “Radiation responses of perfused tracheal 
tissue” by J.R. Ford, A.J. Maslowski, R.A. Redd and L.A. Braby, 2005.  Radiation Resarch, 164, 487-492.  
Copyright 2005 by Radiation Research 
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Despite the importance of using tissue structures for radiation biology experiments, there 
are considerable experimental limitations in performing all such experiments on systems 
that maintain tissue matrices and mimic in vivo environments; nevertheless, 
experimental systems that are closer to this 3-D organization can be more directly 
compared to in vivo results.  Attempts to emulate in vivo environments have been tried 
with success.  The Whitcutt chamber, which is often used for tracheal cells, allows for 
epithelial cells to differentiate while maintaining an air-liquid interface (45, 46).  Cells 
are grown on collagen treated porous membranes that allow for media to nourish the 
basal layer and the ciliated and secretory cells to maintain apical contact.  This model, 
however, does not maintain the tracheal fibroblasts or cartilage rings.  Collier, et al. also 
attempted to maintain the in vivo environment by using ring organ cultures (47).  This 
design incubates trachea rings, cut transversely and having one cartilage ring intact, in 
Petri dishes with media.  In contrast to the Whitcutt chamber, this model does maintain 
the fibroblasts and the cartilage rings, but it does not have an air-liquid interface.   Each 
model offers an improvement to the widely used cell culture model, but neither is able to 
include significant trachea features: multiple cell layers, the cartilage rings and the 
liquid-air interface.   
 
Cell behavior has been found to be determined not only by its genome, but by its 
microenvironment.  Early experiments found that injecting carcinogenic cells into a 
normal tissue environment would cause the cells to revert to a normal tissue (48).  In 
addition to cancerous cells reverting to a normal phenotype, studies have used mouse 
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mammary epithelial cells as a model to determine if normal tissue could become pre-
neoplastic through the influence of the tissue microenvironment (35, 49-51).  While a 
definite answer to this question remains elusive, the results further confirm the 
correlation between a well structured microenvironment and tissue health.  If a well 
structured ECM is important for a healthy functioning tissue, then what effect does 
irradiating a tissue have on the ECM and the tissue as a whole?  Barcellos-Hoff, et al. 
found that irradiation of mouse mammary stroma promoted neoplastic formation by 
altering the ECM and growth factor activities (52).  These results are based on low-LET 
gamma irradiation; however, similar ECM reorganization was found after irradiating 
mouse mammary glands with high-LET iron particles (53).  Therefore, it is unclear if 
radiation carcinogenesis is a contributing factor or the result of disrupting the tissue 
microenvironment.  In lungs, this same disruptive reorganization is called fibrosis and is 
known to result from high-LET irradiation (54).  Therefore, to investigate the radiation 
effects on the ECM in lungs, a previously developed ex vivo tracheal model has been 
adapted for this study.   
 
In 1981, Gabridge and Hoglund developed a unique matrix-embedded perfusion system 
for guinea pig trachea (55) which was later used for hamster trachea (56).  The system 
design allowed for an intact, ex vivo trachea to maintain a near normal metabolism, 
structure and function for a short time.  After aseptically removing a guinea pig trachea, 
it was embedded in an agar matrix and placed in a Teflon® block.  The Teflon® block 
was manufactured with a well on each end with a narrow canal, where the trachea would 
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be embedded, connecting the two (see Fig. 4).  The design allowed for media to flow 
from well to well through the tracheal lumen while gently washing the trachea with 
nutrient rich media.     
 
 
FIG. 4.  Diagram of the perfusion chamber designed by Gabridge and Hoglund.  
Adapted from Gabridge and Hoglund, 1981 (55, 56). 
 
 
 
While this perfusion chamber design was useful for experiments researching the effects 
of chemical toxins, the Teflon® block limited the use of the perfusion chamber in 
radiation experiments; therefore, its design was modified to limit the shielding of the 
radiation by the supporting block.   
 
The Teflon® block was redesigned for this research; however, the basic concept of the 
perfusion chamber, i.e., the flow of media through the tracheal lumen, was retained.  
Based on the expectation of having multiple trachea samples for irradiation, we chose a 
commercially available cover slip well as our container (see Fig. 5).  This design 
allowed for all the benefits of the original perfusion chamber’s original design while 
reducing the shielding of the trachea.  The reduced shielding was an important 
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characteristic for the experiment because we wanted to ensure the accelerator and x-ray 
irradiations delivered the dose determined by the dosimetry measurements.  This helped 
to reduce the uncertainty of the irradiations.      
 
 
FIG. 5.  Pictured is a perfusion chamber with a nearly full length (~2cm) trachea that 
was cast in an agarose block. 
 
 
Tracheal Epithelium Repopulation  
The goal of establishing a perfusion chamber system, which would maintain a trachea ex 
vivo, was to establish another bridge between cellular and in vivo models.  Currently, 
xenografts serve as the primary example of a model that maintains the extracellular 
environment, multiple cell types, and is used to connect cellular and in vivo model 
results.  Xenografts are used for multiple organs, but are particularly well suited for 
trachea experiments. 
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Rat tracheal xenografts are tracheas which have been excised and subcutaneously 
transplanted in a host animal.  The host animal accepts the graft, develops a 
vascularization system to the trachea, and the viability of the trachea is maintained in the 
host.  This model has been used to determine the effects of carcinogens on rat tracheal 
epithelial cells by placing a pellet of carcinogenic material in the trachea prior to 
transplantation (57).  Further research has shown that excised, denuded tracheas can be 
repopulated with epithelial cells, transplanted subcutaneously in rats, and exposed to 
carcinogens (57, 58).  Denuded trachea provided the basal lamina architecture necessary 
for extrinsic epithelial cells to attach, differentiate, and reconstitute the epithelium.  The 
success of repopulating denuded trachea suggested the possibility of repopulating 
denuded trachea with human epithelial cells.   
 
Experiments using human cells to repopulate denuded rat tracheas have been achieved 
(59-61).  This success provided another step in the bridge connecting animal data to 
human data.  This is a step we wanted to achieve to more closely relate the results of the 
perfusion chamber system to human cells.  This would be attempted by repopulating a 
denuded trachea with human bronchial epithelial cells using the perfusion chamber 
model. 
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Materials and Methods 
Animals 
Young adult male Fischer 344 (~300 g) rats (Harlan, Indianapolis, IN) were housed in 
approved animal facilities and tracheal tissue was harvested using methods approved by 
the institutional Animal Care Committees of Texas A&M University and Brookhaven 
National Laboratory, and conformed to NIH guidelines. 
 
Tissue harvest 
To obtain tracheas for perfusion cultures a wide anterior thoracotomy was performed 
under terminal anesthesia.  Terminal anesthesia was accomplished by intraperitoneal (IP) 
injection of sodium pentobarbital at a dose of 140 mg/kg.  After exposure of the anterior 
mediastinum under strict aseptic conditions, the tracheas were separated from the 
surrounding tissues by blunt dissection.  The tracheas were freed by cutting just above 
the bifurcation and below the larynx.  The tracheas were stored for several hours on ice 
in complete medium while the chambers were prepared. 
 
Media 
The media for the perfusion chamber trachea was made of two sets of ingredients.  The 
first, B1, was used for primary epithelial cell repopulation experiments.  B1 was 
prepared at two times the necessary growth factor concentration, and consisted of the 
following components and concentrations: Ham’s F-12 (95%, Gibco, Grand Island, NY), 
Epidermal Growth Factor (0.004%, Gibco, Grand Island, NY), gentamicin (0.2%, Gibco, 
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Grand Island, NY), hydrocortisone (0.02%, Gibco, Grand Island, NY), insulin (0.1%, 
Gibco, Grand Island, NY), and Fetal Bovine Serum (5.0%, Gibco, Grand Island, NY).  
Media used for normal human bronchial epithelial repopulation experiments, BEGM, 
was also prepared with two times the necessary growth factor concentration and 
consisted of the following components and concentrations:  Ham’s F-12 (92.8%, 
Cambrex, Walkersville, MD), Fetal Bovine Serum (5%, Gibco, Grand Island, NY), 
Human Epidermal Growth Factor (0.2%, Gibco, Grand Island, NY), gentamicin (0.2%, 
Gibco, Grand Island, NY), hydrocortisone (0.2%, Gibco, Grand Island, NY), insulin 
(0.2%, Gibco, Grand Island, NY), transferrin (0.2%, Gibco, Grand Island, NY), Bovine 
Pituitary Extract (0.8%, Gibco, Grand Island, NY), epinephrine (0.2%, Gibco, Grand 
Island, NY), triiodothyronine (0.2%, Gibco, Grand Island, NY).      
 
Perfusion chambers 
Tracheal perfusion chambers were made using a modification of the techniques of 
Gabridge and Hoglund (55) and Marcus and Baker (56).  The tracheas were trimmed to 
remove any rough edges and were placed into the chambered coverglass wells (Lab-Tek, 
Naperville, IL) that were used as perfusion chambers (Fig. 6).  Medium (62) made with 
twice the normal quantities of growth factors (2X) was mixed with 3% agarose in equal 
quantities.  This agarose mixture was poured over the trachea placed in the perfusion 
chamber and placed in the refrigerator to harden.  Once the agarose mixture hardened the 
trachea was rinsed with medium to insure that the lumen was clear and free flowing.  
The medium reservoir that remained on either side of the trachea was filled with a 
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minimal volume of medium and the chamber was placed on an oscillating table.  The 
gentle rocking motion insured that the entire tissue sample was periodically washed with 
medium providing nourishment, while still providing air exposure.  Washing of the 
tracheal lumen occurred every seven seconds, or approximately eight times per minute.   
 
 
 
 
 
 
FIG. 6.  Diagramed is a Lab-Tek® chambered coverglass well with dimensions: 5cm x 
2cm x 1.1cm.  The coverglass well is used for the adapted perfusion chamber. 
 
 
 
Tracheas were denuded by incubating on the rocker for 30 minutes using 1.0% of Triton-
X 100 (Sigma, St. Louis, MO).  After incubation, the trachea’s lumen was rinsed with 
BEGM media until no visible cells were flaking off.  This treatment prepared the trachea 
for repopulation with suspension of primary culture cells.   
 
Cells 
Cells used to repopulate the denuded trachea came from primary tracheal cell cultures or 
an established human bronchial epithelial cell line.  Primary tracheal epithelial cells were 
obtained as follows.  Tracheas freshly removed were cut through the ventral rings, and 
filled with 1% pronase (Sigma, St. Louis, MO) in Hanks’ buffered saline solution 
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(Gibco, Grand Island, NY) and were incubated for 18.5 hours at 4°C.  After incubation, 
cells were removed by repeated flushing of the lumen with 10 mL of cold B1 media.  
Cells from three to five tracheas were pooled, centrifuged for 10 minutes at 800 rpm, and 
the supernatant was then removed.  The cells were resuspended in B1 media with 1 mL 
of DNAse and allowed to sit at room temperature for five to ten minutes.  The cell 
suspension was then passed through a 5 mL pipette ten times, a 19 gauge needle by 
syringe 20 times, and then passed to a 27 gauge needle by syringe.  The cells were then 
suspended in medium and seeded.  The other cell line, normal human bronchial 
epithelial cells (CC-2541, Cambrex, West Chester, PA), was removed from 
cryopreservation and resuspended using BEGM media.  The nHBEC’s were plated in 25 
cm2 flasks with BEGM media at a density of 10,000 cells/cm2.  When the cells were 
needed for repopulation experiments, 3 mL of trypsin was added for five minutes.  After 
five minutes, 6 mL of trypsin neutralizing solution was added and the cells were 
centrifuged at 800 rpm for five minutes.  The supernatant was removed, the cells 
resuspended in 10 mL of BEGM, and the cells were ready for repopulation experiments.     
 
Tissue staining 
Formalin-fixed tracheal sections were examined using propidium iodide (0.5 µg/mL, 
Molecular Probes, Eugene, OR) to aid identification of cell nuclei and PCNA antibodies 
(1:100 in 5% normal horse serum, Zymed Laboratories Inc., San Francisco, CA) to aid 
identification of cycling cells and DNA repair.  The samples were coverslipped with a 
commercially available anti-fade agent (Vector) and stored in a refrigerator until viewed 
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with the Axiovert 200M microscope (Carl Zeiss, Thornwood, NY).  Three samples were 
used for each data time point, and there were twelve fields, corresponding to 
approximately 200 µm, for each trachea sample.   
 
Results 
Comparison of tracheal cell density and apoptotic index versus time in perfusion 
chamber 
To determine the viability of the tracheal samples maintained in the coverglass wells, we 
investigated the number of apoptotic bodies in the trachea over time.  It was found that 
the number of epithelial apoptotic bodies remained constant for one and three days, 
however, there was a large increase at day seven (Fig. 7).  Further analysis of the 
epithelial layer condition was required due to the large increase of apoptotic bodies at 
day seven.  Therefore, tracheal tissue was stained with propidium iodide and viewed 
using a fluorescent microscope.   
 
Inspection of the stained tracheal tissue after seven days in the perfusion chamber found 
that the epithelial layer loses cell density as compared to one day in the perfusion 
chamber (Fig. 8).   Due to the reduction in cell density and the increase of apoptotic 
bodies, the tracheal irradiations were planned to occur within 24 hours of placement in 
the perfusion chamber, and the trachea did not remain longer than three days in the 
perfusion chamber before fixation.   
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FIG. 7.  Cell density and number of apoptotic bodies compared to time in  
perfusion culture. 
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A 
 
 
B 
FIG. 8.  Propidium iodide stained trachea after 18 hours (A) and seven days (B).   
There is a reduction in cell density of the epithelial layer at seven days in  
the perfusion chamber as compared to 18 hours in the perfusion chamber. 
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Apoptotic index versus position in perfusion chamber 
The apoptotic index versus region of the trachea was also measured in an effort to 
determine why the large increase occurred at day seven (see Fig. 9).  It was determined 
that passing the media across the bottom of the trachea, as it sat in the perfusion 
chamber, caused physical damage to the bottom of the trachea over time; thus, there was 
an increase in the apoptotic damage in this area.  Correspondingly, the tracheas were 
found to have a very low apoptotic index at the top of the perfusion chamber trachea.   
 
 
FIG. 9.  The number of apoptotic bodies in different regions of the trachea maintained in 
a perfusion chamber for seven days. 
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PCNA levels versus time in perfusion chamber  
Proliferating cell nuclear antigen (PCNA) is a sliding DNA clamp that is found at sites 
of DNA repair and replication.  Due to its role, PCNA is often used to identify if a cell is 
undergoing high levels of repair or replication (63).  In this experiment, PCNA 
antibodies were used to ensure that tracheas maintained in the coverglass wells were not 
showing disproportionate PCNA levels as compared to fresh trachea.  Figure 10 shows 
the PCNA levels for the one-day perfusion chamber trachea increase as compared to the 
fresh trachea; however, there are no substantial increases for day three and seven.  In 
addition, the standard deviation between day three and the fresh trachea is not 
significant.  
 
FIG. 10.  Average number of PCNA positive cells as compared to  
time in perfusion chamber. 
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These results show that tracheal cells maintained in the coverglass well are not 
undergoing significant increases in DNA repair and replication.  This is an important 
result because it indicates the perfusion chamber tracheas are maintaining normal 
physiology and monitoring damage after irradiation may be possible.   
 
Repopulated trachea with human cells 
Repopulation of denuded trachea is a technique that has been used to test carcinogens on 
human tracheal epithelial cells in xenografts.  The success of this model has allowed for 
a closer connection between human and cellular data.  In an attempt to provide another 
model, which could be used to relate human and cellular data, we investigated if 
denuded trachea maintained in a perfusion chamber could reconstitute the epithelium.  
The results indicate that the trachea could be successfully denuded of the epithelium 
(Fig. 11); however, attempts to repopulate the trachea with human bronchial epithelial 
cells were unsuccessful (Fig. 12).  It was thought that the repopulation would be more 
successful if epithelial cells, harvested from primary trachea, were used instead.  This 
attempt at repopulating the trachea was also unsuccessful (Fig. 13).   
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FIG. 11.  Triton-X 100 denuded rat trachea image. 
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FIG. 12.  A repopulated rat trachea with normal human bronchial epithelial cells. 
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FIG. 13. A repopulated rat trachea with primary rat tracheal epithelial cells. 
 
 
The perfusion chamber model relies on the washing of the trachea’s lumen with media, 
by the rocking of the perfusion chamber, to nourish the tissue.  Therefore, with each 
washing of the lumen, there is a possibility of washing out introduced cells.  Thus, this 
technique is not conducive to the attachment of cells in suspension introduced into the 
lumen of a perfusion chamber trachea.  In the xenograft model, sutures close each end of 
the trachea prior to transplantation into the host animal.  This allows for all carcinogens, 
and extrinsic cells introduced, to remain within the lumen.  This was not a possibility in 
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our model; consequently, we were not able to repopulate the denuded, perfusion 
chamber trachea with new cells. 
 
Discussion 
The adaptation of the original perfusion chamber design by Gabridge and Hoglund as 
well as Marcus and Baker for irradiation of rat tracheal tissue was successfully 
demonstrated.  After analysis of propidium iodide staining, physical damage to the 
epithelium, and PCNA antibody reaction, it was determined that the coverglass well 
maintains the tracheal tissue in acceptable condition for up to three days.  After three 
days, the trachea began to exhibit increased stress and damage to its physiology and 
morphology.  Therefore, in order to ensure experiments using perfusion chambers were 
performed at the peak of the trachea’s viability, irradiation experiments were to be 
performed within the first 24 hours and to remain in the perfusion chamber less than 72 
hours.  Performing experiments outside of this window would introduce increased 
variability into the experiment and we did not expect it to provide significant results with 
the increased time.     
 
In addition to ensuring viability, it was necessary to adapt the original perfusion chamber 
design materials to commercially available ones.  The material previously used was not 
suitable to our irradiations due its thickness and density.  Due to its minimal thickness, 
the new coverglass wells would not excessively shield the trachea or cause extreme 
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scattering of the ion beam before reaching the trachea.  This material characteristic was 
important to ensure that the dosimetry measurements for the accelerator and x-ray 
irradiations were consistent.  The standard coverglass well helped reduced variability in 
the irradiations as well as between perfusion chamber preparations.   
 
The nature of working with tissue explants in experimental models introduces numerous 
variables (multiple cell types, cartilage rings, increased cell-cell signaling, 
uncontrollable growth factors, nutrition needs) due solely to its structure.  In an effort to 
reduce these, a consistent perfusion system based on commercially available materials 
was designed and tested.  After analysis of the trachea response (apoptotic bodies, 
PCNA response, and physical damage to the epithelium), it was found the trachea was 
viable up to three days in the perfusion chamber system.  Based on these results, the 
perfusion chamber model was used for the following radiation response experiments.   
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CHAPTER III 
GENE EXPRESSION ASPECTS OF MODEL DESIGN 
 
Underlying any argument for the use of a linear extrapolation to obtain the risk resulting 
from low doses of radiation is the assumption that the adverse effect is the result of an 
individual cell acting autonomously.  Single particle microbeam irradiation has shown 
that at least some biological endpoints can be produced by passage of a single alpha 
particle through a cell (64).  There is adequate evidence that the health effect of greatest 
concern, cancer, is the result of the abnormal growth of a single cell.  It is also known 
that, under normal circumstances, cells are influenced in many ways by their local 
environment.  Cells are stimulated to divide, differentiate, or self-destruct depending on 
signals from neighboring cells and the extracellular matrix.  There is also evidence that 
some members of an irradiated population alter their levels of repair related proteins 
(65), and change their DNA metabolism (22, 66, 67), even though they could not have 
been directly hit by an ionizing particle.  This strongly suggests that cells do not act 
autonomously, and it may be that interactions between hit and unhit cells influence the 
probability of adverse effects in ways that depend on the number of hit cells in the 
population, that is, in a dose-dependent way (18-21).  A nonlinear, dose-dependent 
modification of the probability of expressing radiation damage would clearly result in a 
nonlinear response at low doses.  The problem for radiation biology is to determine the 
nature of this interaction and the probability for relevant biological effects, and thus 
provide data for improving the reliability of health risk estimates at low doses. 
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Several characteristics of the radiation and the target system are likely to influence the 
magnitude and frequency of modifications to the response of individual cells.  The 
obvious properties of the radiation are the energy deposited, mass and velocity of the 
charged particle, the spatial distribution of the charged particle tracks, and the temporal 
distribution of events.  
 
The rat tracheal epithelial cell culture/ex vivo model system enables us to examine 
effects in the tissue directly under culture conditions that more closely resemble the 
environment that respiratory epithelial cells encounter in the animal.  The rat tracheal 
epithelial cell system has been well characterized for a large number of different 
endpoints (68-70).  Preneoplastic transformation is influenced by the concentration of 
TGF-beta in this system (41, 42) and TGF-beta has been implicated as a possible 
mediator of some reported bystander effects (19, 43).  The rat tracheal epithelial cells 
exhibit extensive gap-junction mediated, cell-cell communication in culture and in the 
tissue.  Neoplastic progression in this system is also correlated with changes in cell-cell 
communication (71).  Gap junction communication has been suggested in a number of 
bystander effects (72).  Interactions between stromal cells and epithelial cells are known 
to be important in some tissue models of carcinogenesis and have been suggested as 
important factors in bystander effects and genomic instability (19). All of these types of 
interactions can be quantified in the rat tracheal system.  In the evaluation of risk it is 
important to know the probability that an initiated cell will progress to neoplasia and the 
rat tracheal system has been used to examine the interactions between altered (initiated, 
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preneoplastic or tumorigenic) cells and normal unaltered cells (73).  Studies have also 
been performed comparing the response of intact tracheal transplants and cells in culture 
for a wide variety of radiations and carcinogens. 
 
In this chapter the effects of radiation on gene expression in perfusion cultures of rat 
tracheal sections is examined.  This new culture system takes advantage of the previous 
information obtained with primary tracheal epithelial cells in monolayers and paves the 
way for microbeam or low fluence ion irradiation of thin tissue sections.  By controlling 
the spatial and temporal distribution of dose in a model system that closely approximates 
the normal tissue milieu, we can quantify any adverse or beneficial bystander effects due 
to radiation. 
 
Materials and Methods 
The materials and methods used for the housing of animals, harvesting tissue, and 
perfusion chamber preparation for the following experiments are as described in Chapter 
II.   
 
Chamber irradiation 
Chambers were irradiated with either x-rays (250 kVp and 10 mA delivered at 1 Gy/min 
at Texas A&M) or placed parallel (or perpendicular) to the beam of the Alternating 
Gradient Synchrotron (1 Gev/nucleon iron ions, delivered at 0.5 Gy/min).  Chambers 
received 4 Gy of x-rays or either 0.05 Gy or 0.1 Gy of iron ions. Sham exposures were 
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carried out for both types of exposure by placing the chambers in the irradiation position 
for the same time period without energizing the beams.  
 
Immunohistochemistry 
Formalin fixed tracheal sections were examined using mouse monoclonal antibodies to 
PCNA (Zymed, South San Francisco, CA).  Samples were blocked with horse serum for 
an hour and then treated with the specific monoclonal antibody for one hour.  Secondary 
antibodies (horse anti-mouse) conjugated to fluorescein isothiocyanate (Vector, 
Burlingame, CA) were added after repeated rinsing and left to incubate for an hour at 
room temperature.  After repeated rinsing the samples were counterstained with 
propidium iodide (0.5 µg/mL, Molecular Probes, Eugene, OR) to aid identification of the 
cell nuclei.  The samples were coverslipped with a commercially available anti-fade 
agent (Vector) and stored in a refrigerator until viewed with the Axiovert 200M 
microscope (Carl Zeiss, Thornwood, NY). 
 
Results 
Comparison of tissue maintained in perfusion chambers to freshly harvested tissue. 
From preliminary experiments we had determined that an intact epithelium could be 
maintained for several days.  Measurements of proliferative index, apoptotic index, cell 
number, and relative proportions of basal cells to ciliated and secretory cells were not 
significantly different for the first week of culture (see Chapter II).  Although we knew 
the cells were present (Fig. 14) and appeared healthy by these measures, we wanted to 
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determine if cell behavior as characterized by gene expression were identical to normal 
tissue freshly harvested from the animals. 
 
 
FIG. 14.  Histology section from a 1-day-old perfusion chamber (H&E-stained  
section, bright-field, 63X objective) from the set that was exposed to iron  
ions at Brookhaven National Laboratory. 
 
 
Changes in gene expression 
Arrays were analyzed for mRNA obtained from three tracheas maintained for 24 hours 
in perfusion culture (sham exposed) and for three age-matched freshly harvested 
tracheas (one array for each sample for a total of six arrays).  A total of 1718 of the 
sequences were judged to be under expressed; that is, the intensity of the signal from the 
samples obtained from perfusion chambers was less than half the value detected for 
freshly harvested samples.   Another 891 sequences were judged to be over expressed 
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(more than twice the intensity) in the perfusion culture samples while the remaining 
7212 sequences demonstrated no significant differences (Fig. 15). 
 
 
FIG. 15.  Genes (or ESTs) that remained unchanged, were overexpressed (≥two times), 
or were underexpresseed (≤0.5) in perfusion chamber samples compared to freshly 
harvested trachea. 
 
After excluding unknown sequences, the most striking over expressions were in genes 
associated with mucus production and secretion.  In particular lipocalin (80X) and 
surfactant associated protein (30X), were the most expressed genes in the perfused 
tissue.  Examination of genes associated with apoptosis, hypoxia, cell-cycle control, 
inflammation, TGF-beta, and stress pathways (determined by using the databases 
available through PubMed, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) were not 
significantly different, in keeping with our general histological observations.  Further 
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analysis of the gene expression in perfused trachea can be found in Ford, et al. (62). 
 
Discussion 
Previous observations using the rat tracheal epithelial cell system demonstrated that, 
regardless of whether cells were irradiated as a single-cell suspension or in the trachea 
and then introduced immediately into primary culture, the same survival dose response 
would be obtained for a particular type of radiation (74).  When these experiments were 
originally conceived, it was with the expectation that perfused tracheal sections 
irradiated with a low fluence of ions would demonstrate the same bystander effects 
observed for primary cells in culture.  Instead of the expected 25-30% of the irradiated 
epithelial cells exhibiting detergent resistant PCNA less than 1% of the cells were 
PCNA+.  The lack of an observable change in the fraction of cells exhibiting detergent-
resistant PCNA led to an examination of gene expression profiles to begin to define 
possible differences that might be responsible for this result.  Since the main purpose of 
this research was to determine the degree to which bystander effects play a role in the 
risk of cancer in respiratory tissue, it was necessary to study the differences between 
perfused tissue and freshly harvested tissue.  In general, the answer was that the gene 
expression was not significantly different for most sequences examined (Fig. 15).  Those 
changes that detected were mainly due to increases in genes connected to mucus 
secretion.  This indicated that the gently rocking used to keep the tissue moist is 
probably stimulating mucus secretion and is not as gentle as first thought.  Whether the 
stimulation of ciliated and secretory cells might perturb a response to radiation will 
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require further investigation.  
 
One well known gene did exhibit the expected increase in expression following 
irradiation. Although CDKN1A expression had increased eight-fold, it did not show as 
dramatic an increase as might have been expected from experiments with cell lines (75).   
Most of the other sequences examined showed no difference but the samples were 
obtained just two hours post-irradiation.  The effects were studied early because there 
was concern that cell loss to the medium would skew the mRNA distribution in favor of 
surviving cells and because bystander or adaptive responses occur within a few hours.   
This led to consideration of another possibility that might also affect the ability to 
monitor gene expression.  There are three distinct cell types that make up the 
pseudostratified epithelial lining of the trachea.  The basal cells are the only cells which 
can proliferate and the other two cell-types (ciliated and secretory) have specialized 
functions that require the expression of distinct sets of genes.  This is illustrated in Fig. 
16 where the staining for PCNA is restricted to a few cells of the basal layer.   
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FIG.  16.  One-day-old perfusion chamber treated with anti-PCNA antibody to visualize 
detergent insoluable PCNA.  The cycling cells are restricted to the basal cell layer (at the 
same magnification as in Fig. 14). 
 
 
In cell culture, it has been shown that it is the basal cells that act as clonogens in primary 
culture (76).  Therefore, it is proposed that terminally differentiated cells do not respond 
to irradiation and that only a small fraction of cells, the tissue stem cells, will respond by 
changes in gene expression and that the presence of the other cell types dilutes the 
increased expression in responding cells.  In the future, this hypothesis will be tested by 
separating the different cell types and examining the gene expression in different cell 
fractions.  Based on these results, it is expected that the cell-cycle arrest and possibly 
repair genes will be over-expressed in the basal cells while they would remain relatively 
unchanged, if expressed at all, in the ciliated and secretory cells.  The possibility that a 
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significant proportion of cells may not respond markedly to irradiation, or respond 
differently, could also explain some of the differences that have been reported in the 
effect of different types of radiation on tumorigenesis in the rat tracheal system (77). 
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CHAPTER IV 
COMPARATIVE EFFECTS OF LOW-LET AND HIGH-LET ON  
THE TGF-BETA RESPONSE OF TISSUE 
 
The radiation environment in space is dominated by two sources: galactic cosmic rays 
(GCR) and solar particle events (SPE).  GCR are ubiquitous and isotropic and SPE are 
irregular and unpredictable; however, neither source is easily shielded.  As a result of 
these sources, the radiation environment in space consists of a multitude of radiation 
types including: electrons, protons, positrons, neutrons, alpha particles, fission 
fragments, hydrogen, helium, carbon, neon, oxygen, silicon, and iron ions.  These 
particles can range in energy from 10 MeV/n to 10 GeV/n.  It is because of this mixed 
field of high-LET and low-LET radiation that it is difficult to shield astronauts from 
solar events or during extended space travel.     
 
HZE particles make up approximately 1% of GCR, but are a significant contributor to 
dose in low-earth orbit because of their weight and high energy.  Of all the particles in 
the spectrum, iron is thought to be the most important because of its relatively high-LET 
(5).  A 1GeV iron particle has a LET of 146 keV/µm.  In addition, an iron particle can 
produce significant delta rays as a result of its interaction with matter.  Because of these 
characteristics of iron ions, its effect on biological systems is not completely understood, 
nor can it be directly extrapolated from alpha particles, electrons or x-rays.  Research 
into understanding this effect was conducted by Burns et al., and it was found that 
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electrons have a lower carcinogenic effectiveness than argon ions for skin tumor 
induction in rats (16).  Moreover, the argon ion dose response seemed to follow a linear-
quadratic response; however, the electron dose response was a dose cubed power 
function.  Burns et al. hypothesize that this effect may result from the fact that the 
response to injury for each radiation type is by a different pathway.  The different 
response pathways make it difficult to extrapolate dose response from a low-LET 
electron to a high-LET HZE particle; thus, experiments investigating the effects of HZE 
particles on biological tissue are necessary to understand all the repercussions of HZE 
exposure.   
 
Therapeutic radiation exposure and accidental overexposures can result in the excess 
deposition of extracellular matrix components, or fibrosis.  This wound response is often 
described as dead scar tissue (78); however, recently published research describes 
fibrosis differently.  It has been determined that fibrosis is an active process which 
continuously reorganizes extracellular matrix components (34).  Normally once a tissue 
repair response has been initiated, negative feedback mechanisms will conclude the 
repair response once the epithelium is fully regenerated.  If this negative feedback is not 
initiated, or is somehow curtailed, then the tissue continually deposits and reorganizes 
the extracellular matrix; thus, resulting in fibrosis.  Understanding the tissue response 
and why the interruption of the signal process results in fibrosis is necessary in order to 
treat or prevent a fibrotic response.  There is still a great deal of research needed to 
complete this understanding; however, the initial activation of the repair response has 
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been determined to be caused by the activation of the cytokine, TGF-beta.    
 
TGF-beta is known to have a significant role in a tissue’s response to injury.  This role is 
well defined for mechanical injury of tissue; however, it has just recently been 
investigated for its role in radiation-induced injury.  Radiation-induced injury is 
sometimes considered a more dangerous type of injury because the stimulant is spread 
over a large area, but it has been shown that the tissue responds in a very similar 
pathway as it does to mechanical injury (79).  Therefore, TGF-beta may also have just as 
significant a role in radiation-induced injury as in mechanical injury.  In fact, research 
has shown that there is an over-response of TGF-beta in post-radiation treated cancer 
patients (34, 80-82).  This excess response has been shown to cause fibrosis, which is a 
known precursor to carcinogenesis (83, 84).  Bonniaud et al. have shown that if Smad3, 
the cytokine that is downstream in the signaling pathway of TGF-beta, is knocked out, 
there is no evidence of fibrosis or excess collagen accumulation.   
 
TGF-beta is known to be activated in the response to radiation injury, and the 
interruption of its pathway downstream results in no fibrosis or collagen accumulation 
(83).  Recent studies have also shown that irradiation of TFG-beta null mice had reduced 
downstream DNA damage (85) and null embryos fail to undergo apoptosis or inhibition 
of the cell cycle (86).  These data show the importance of TGF-beta in the response to 
radiation, but the experiments focused on low-LET gamma-rays.  Due to the different 
response of tissue to high and low-LET seen by Burns et al. the question of how the 
  
51 
TGF-beta pathway would respond to high-LET particles is left unanswered.   
The movement of space travel to longer time and distances requires that future 
experiments address the variables astronauts would expect to see for such missions.  The 
mixed field of high and low-LET radiation is a significant source of uncertainty, 
especially when trying to determine the fibrotic response in lung tissue.  Recent 
experiments have shown that rat tissue responds differently to low and high-LET 
radiation and that TGF-beta activation is a precursor to fibrosis for low-LET irradiations; 
however, there is a lack of data addressing how TGF-beta will respond to high-LET 
radiation.  The following experiments use the previously established perfusion chamber 
system as an ex vivo environment for determining if a change in TGF-beta response can 
be measured for high and low-LET irradiation.  It is believed that by using a complete 
tissue model for measuring the response, a result that can be more closely related to what 
would be seen in vivo can be expected.   
 
Materials and Methods 
The materials and methods used for the housing of animals, harvesting tissue, and 
perfusion chamber preparation for the following experiments are as described in Chapter 
II.   
 
Media 
The media for the Brookhaven National Laboratory perfusion chamber trachea, BNL1, 
was prepared with two times the necessary growth factor components and later diluted 
  
52 
with Ham’s F-12 for the normal concentration.  BNL1, with two times the growth 
factors, consisted of the following components: Ham’s F-12 (90.5%, Cambrex, 
Walkersville, MD), BSA-Factor V 7.5% (Gibco, Grand Island, NY), hEGF (0.004%, 
Cambrex, Walkersville, MD), gentamicin (0.2%, Cambrex, Walkersville, MD), 
hydrocortisone (0.02%, Cambrex, Walkersville, MD), insulin (0.1%, Cambrex, 
Walkersville, MD), transferrin (0.2%, Cambrex, Walkersville, MD), BPE (0.8%, 
Cambrex, Walkersville, MD). 
 
Antibodies 
Anti-TGF-beta antibody (R&D Systems, Minneapolis, MN) was used to pre-treat the 
perfusion chamber tracheas at 100 ng/mL concentration.  This concentration corresponds 
to an approximate bioactivity neutralization of 95%.  Samples were treated three hours 
prior to irradiation to insure sufficient time for the antibody to neutralize TGF-beta 
activity. 
 
TGF-beta detection was completed using a rabbit polyclonal TGF-beta antibody (NIH, 
Kathy Flanders).  After a sample were prepared and deparaffined, the slide was washed 
with cold Dulbecco’s PBS (Gibco, Grand Island, NY) three times.  The sample was then 
treated with a detergent wash (0.1% Trition X-100, Sigma, St. Louis, MO; 0.1% SSC, 
EM Science, Gibbstown, NJ) for two minutes and washed two times with PBS.  The 
sample was blocked with 5% normal goat serum (Vector, Burlingame, CA) in DPBS for 
one hour at room temperature.  LC-1-30-1 (S) rabbit anti-TGF-beta1 at 2 µg/mL in 5% 
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normal goat serum and DPBS was used to treat the sample for one hour at room 
temperature.  After an hour, the sample was rinsed two times with DPBS and treated for 
30 minutes with FITC-goat-anti-rabbit IgG (Zymed, San Francisco, CA) at a 1:200 
concentration in 5% normal goat serum and DPBS.  During this treatment the samples 
were kept in the dark to avoid bleaching of the fluorescein label.  After fluorescein 
treatment, the sample was rinsed three times with DPBS and then distilled water.  The 
sample was then blotted dry, treated with Vectashield (Vector, Burlingame, CA) and 
coverslipped.  Finished samples were stored at 4° C.   
 
Irradiations 
X-ray irradiations were conducted at the Nuclear Science Center of Texas A&M 
University using a Norelco x-ray machine.  All irradiations used 250 kVp x-rays.  All 
HZE irradiations were conducted at Brookhaven National Laboratory’s NASA Space 
Radiation Laboratory using 1Gev Fe particles.   
 
Results 
TGF-beta response after x-ray irradiation 
Measurement of the TGF-beta antibody response for each x-ray treated tracheal section 
was made to determine if a response could be seen given the large auto fluorescence 
background intrinsic to tissue.  Of the green spectrum, the signal used for analysis 
focused on bins 25 to 75 of 0 to 255 (white to bright green).  It was determined that bins 
25 to 75 provided the most fluorescence data directly correlating to a positive antibody 
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response and did not include bins which were saturated.  In addition, analysis of this bin 
width proved there was no historical trend, or change in the treatment of the samples 
over time, in the fluorescence data.  Once the correct bin width was determined, the 
negative antibody control, minus plus, was then subtracted from the positive control, 
plus plus, in order to see only the TGF-beta contribution to the signal.  After subtracting 
the negative control from the positive TGF-beta signal, it was found that there was a 
discernable TGF-beta response (Fig. 17). 
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FIG. 17.  The TGF-beta antibody response for 21 trachea irradiated with  
250 kVp x-rays. 
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A 
 
 
B 
FIG. 18.  Perfusion chamber trachea irradiated with 250 kVp x-rays at 2 cGy (A) and 
100 cGy (B) and fixed at 0 hour.  For this fixation time there seems to be an increased 
TGF-beta activation for increased dose. 
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The TGF-beta response after irradiation can be seen in x-ray irradiated tracheal tissue.  
The overall measured TGF-beta activation seems to be directly correlated for the 2 cGy 
and 100 cGy x-ray irradiated 0 hour fixed samples, or those samples fixed immediately 
after irradiation, and can be seen in the tracheal images (see Fig. 18).   
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FIG. 19.  The TGF-beta antibody response for x-ray irradiated trachea  
0 hour post irradiation. 
 
 
 
The 0 hour fixation, 10 cGy x-ray irradiation does not follow the same direct correlation 
found in the 2 cGy and 100 cGy doses (see Fig. 19).  The reason for this is unclear, but 
the high error for the 10 cGy dose may indicate the sample signals are contaminated and 
obstructed by another variable.  However, for the same x-ray dose and increased fixation 
times, 6 hour and 8 hour, the dose response is inversely related (images not shown).   
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Due to the lack of directly correlating doses and TGF-beta responses at each time point, 
a time course for the TGF-beta response for each dose was analyzed (see Fig. 20).  It 
was found that there is a change in response time of the trachea based on the initial dose.  
For the highest dose, 100 cGy, the perfusion chamber trachea responded quickly to the 
irradiation and quickly decreased at six and eight hours.  In contrast, the perfusion 
chamber trachea responded slowly to the 10 cGy irradiation, but had a marked increase 
at 8 hour post irradiation.  Based on these data, the amount and speed of the tissue 
response is determined by the initial dose.   
 
To determine if this response could be modulated, perfusion chambers were treated with 
a commercially available TGF-beta interfering antibody.  A measured decrease of the 
TGF-beta response could be seen in the tracheal images of the TGF-beta interfering 
antibody treated perfusion chambers as compared to the untreated perfusion chamber 
tracheas (see Fig. 21).  Moreover, a reduced TGF-beta response was seen in the blocked  
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FIG. 20.  The TGF-beta response over time of x-ray irradiated trachea  
at 2, 10 and 100 cGy. 
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A 
 
 
B 
 
FIG. 21.  TGF-beta interfering antibody treated (A) and untreated (B) trachea.  Each 
trachea was irradiated with 100 cGy of x-rays and fixed at 0 hour.  There is a reduction 
in the overall TGF-beta response in the epithelial layer in the treated trachea as 
compared to the untreated trachea. 
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TGF-beta perfusion chambers irradiated with x-rays (see Fig. 22).  However, there was 
an increase in the TGF-beta signal at 6 hour and 8 hour post irradiation.  This may 
indicate the interfering antibody was losing effectiveness or the cells were producing 
more TGF-beta.  These data ensured that the TGF-beta blocking antibody was in fact 
blocking the TGF-beta activation during the perfusion chamber irradiations.  Because a 
positive TGF-beta response was measured in x-ray treated perfusion chamber tracheas, 
further experiments were done to determine if a similar response could be found in HZE-
treated tracheas.   
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FIG. 22.  The TGF-beta response over time of TGF-beta antibody interfered irradiated 
trachea at 2, 10 and 100 cGy. 
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Moreover, a reduced TGF-beta response was observed in the blocked TGF-beta 
perfusion chambers irradiated with x-rays (see Fig. 22).  However, there was an increase 
in the TGF-beta signal at 6 hour and 8 hour post irradiation.  This may indicate that the 
interfering antibody was losing effectiveness or the cells were producing more TGF-
beta.   
 
TGF-beta response after HZE irradiation 
TGF-beta antibody experiments with Fe ion treated perfusion chamber tracheas were 
performed and the illumination measured using a light microscope.  It can be seen in Fig. 
23 that there was a significant difference between the negative controls and the positive 
TGF-beta signal (corrected for background).  This response assured that the TGF-beta 
antibody signal could be measured for the x-ray and HZE treated trachea and used to 
determine if there was a change in the overall response of the tissue TGF-beta levels.    
 
  
62 
0.00
2000.00
4000.00
6000.00
8000.00
10000.00
12000.00
14000.00
16000.00
Antibody Treatment
TG
F-
be
ta
 
R
e
s
po
n
s
e
 
fo
r 
B
in
s
 
25
-
75
PlusPlus Area
MinusPlus Area
MinusMinus Area
 
FIG. 23. The TGF-beta antibody response for eight trachea irradiated with  
1 GeV Fe ions. 
 
 
The dose response relationship for HZE irradiations was not as clear as for x-ray 
irradiations.  Similar to the x-ray irradiations, it was found that the overall TGF-beta 
response was higher for a dose of 10 cGy than for 100 cGy at an 8 hour fixation time 
(see Fig. 24 and 25).  Thus, indicating an inverse dose response for TGF-beta to HZE 
irradiations.   
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FIG. 24.  The TGF-beta antibody response for HZE irradiated trachea  
8 hour post irradiation. 
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B 
 
FIG. 25.  Perfusion chamber trachea irradiated with 1 Gev Fe ions at 100 cGy (A) and 
10 cGy (B) and fixed at 8 hour.  For this fixation time there seems to be a decreased 
TGF-beta activation for increased dose. 
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However, the 0 cGy, HZE irradiated sample did not follow the same inverse dose 
relationship seen for 10 cGy and 100 cGy.  Again, the reason for this is unclear but may 
be due to variables interfering with the sample fluorescence.   
 
Comparison of HZE and x-ray TGF-beta response 
After it was determined that the TGF-beta antibody could be used to measure the TGF-
beta response after irradiation, a TGF-beta blocking antibody was used to attempt 
interruption of the downstream effects of TGF-beta.  Measurements of the TGF-beta 
response after irradiation and TGF-beta blocking antibody treatment were taken to 
establish the efficacy of the blocking antibody.  It was determined that a blocking TGF-
beta antibody was effective at inhibiting TGF-beta response after irradiation (see Fig. 
21).   
 
Despite the efficacy of the TGF-beta interfering antibody, there was no clear 
differentiation between the x-ray irradiated trachea blocked for TGF-beta and those that 
were not or between the TGF-beta blocked x-ray and HZE irradiated tracheal tissue (see 
Fig. 26).  Therefore, while the perfusion chamber system was able to provide data for 
overall TGF-beta response, it was not a model that could be used to measure the TGF-
beta response after blocking the TGF-beta pathway using current methods.   
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FIG. 26.  The TGF-beta antibody response for 29 trachea irradiated with 250 kVp  
x-rays and 1 GeV Fe ions. 
 
 
 
Discussion 
Determination of the efficacy of the perfusion chamber as a model for the TGF-beta 
response in tissue was successfully demonstrated.  After analysis of the overall TGF-beta 
response in x-ray and HZE treated samples, for all time points and doses, it was 
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determined that a significant difference could be found between the negative controls 
and the positive samples (corrected for background).  Therefore, the perfusion chamber 
system was found to be a good model for measuring overall TGF-beta response of an ex 
vivo tracheal tissue sample.   
 
In addition to ensuring that the overall TGF-beta result could be measured, it was 
necessary to interrupt the TGF-beta pathway to establish its effect on the tissue response 
to irradiation.  A commercially available TGF-beta blocking antibody was used to block 
the pathway for both x-ray and HZE treated tissue samples.  It is unclear from the data 
whether the blocking antibody was effective in blocking the active TGF-beta.  Early 
indicators showed that for x-ray treated perfusion chamber trachea, the TGF-beta signal 
may be blocked at the 0 hour time point.  The signal does not remain suppressed, and 
actually increases at the 6 hour and 8 hour time points.  This could be due to a loss of 
effectiveness of the blocking antibody or the production of more active TGF-beta.  One 
possibility is that the TGF-beta blocking antibody may not be able to penetrate 
sufficiently to attach and interfere with the active TGF-beta for long periods of time.  
Further investigation is needed to determine the increase in signal after the TGF-beta 
interference.   
 
The benefit of working with a tissue model was the integration of variables not found in 
cell culture models.  Multiple cell types, cartilage rings, increased cell-cell signaling, 
uncontrollable growth factors, etc. all play a role in the response of a tissue to stimuli.  In 
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an effort to incorporate these into the experimental perfusion chamber model, one of 
these factors may have interrupted or compensated for the interrupted TGF-beta 
pathway.  However, it was found that an overall TGF-beta response could be clearly 
measured using TGF-beta antibodies.  The effectiveness of this measurement technique 
could be used to determine changes in the overall TGF-beta response for higher doses 
and multiple particle types.  This TGF-beta measurement will not determine if there is an 
increased extracellular matrix deposition in the tissue, but it could show that a tissue 
TGF-beta response is different for higher doses and multiple particles.   
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CHAPTER V 
CONCLUSIONS 
 
Extended space travel poses a significant risk to the health of the mission team.  Humans 
are well adapted to the terrestrial environment and are unprepared for the harsh 
conditions found in low earth orbit (LEO) and beyond.  This environment consists of 
reduced gravity and a higher background of radiation as compared to the earth’s surface; 
terrestrial organisms are protected by these conditions by earth’s atmosphere and 
intrinsic magnetic fields.  Despite this unique environment, much of the radiation 
research focuses on the gamma-ray effects on cellular models and does not address the 
effects of high-Z-high-energy (HZE) particles on a whole tissue. 
 
The radiation dose an astronaut will be exposed to on long-term missions is thought to 
be one of the most limiting factors for missions.  Because the mission is outside the 
earth’s atmosphere and magnetic field, the team will be exposed to high-LET in addition 
to low-LET radiation.  The two sources of high and low-LET radiation, galactic cosmic 
rays (GCR) and solar particle events (SPE), provide a different radiation spectrum but 
both contain HZE particles including: hydrogen, helium, carbon, neon, oxygen, silicon, 
and iron ions.  Of these, the most significant contributor to the overall HZE dose is iron 
ions due to its high-LET of approximately 146 keV/µm.  HZE particles are known to 
cause damage differently than low-LET radiation and affect the repair process of a cell.  
While low-LET radiation deposits energy in a random distribution through a medium, 
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HZE particles deposit most of their energy localized on the primary particle pathway.  
This localized energy deposition results in a dense ionization path.  In addition, repair 
seems to be affected by high-LET radiation.  The double-strand breaks (DSBs) caused 
by low-LET radiation are repaired at a higher average than those caused by high-LET 
radiation.  Moreover, Goodwin and Blakely found that there is a decrease in the number 
of DSB repaired as the LET is increased (14).  Thus, tissue response to radiation depends 
on the energy deposition pattern of the radiation. 
 
Damage by radiation is also known to cause extracellular damage and may result in 
scarring or fibrosis of the wound area.  The reconstruction of a damaged tissue follows a 
process that is independent of the type of injury (mechanical vs. radiation); however, the 
mechanical repair process tends to be localized as a result of local injury in contrast to 
widespread damage due to irradiation.  In the case of an organism, this overall damage 
can cause organ failure or extensive damage in a specific organ (79).  The repair of 
extracellular damage caused by radiation is known to be initiated by TGF-beta and, in 
the case of whole tissue, can result in tissue fibrosis and later cancer.  The effects of 
TGF-beta activation post-irradiation, and its role in fibrosis, is well established with 
gamma-rays but has not been well studied with HZE particles. 
 
Studies of the effects of HZE on biological systems and the contribution of a tissue to a 
cell’s response to stimuli are moving forward.  More researchers are publishing results 
on the effects of HZE and using whole tissue as a model for organism response to 
  
71 
radiation injury.  However, there are currently no data on how a tracheal tissue responds 
to HZE radiation.  The focus of this study was to determine if a discernable response 
could be measured in an ex vivo tissue model exposed to HZE particles.  Based on this 
hypothesis a working ex vivo model for rat tracheal tissue was developed.  In addition, it 
was shown that this model can be used for radiation experiments, including HZE.  The 
TGF-beta response of the tissue to HZE and x-ray radiation did show a significant 
difference between the negative controls and the positive controls, despite the high auto 
fluorescent background intrinsic to tissue.  The TGF-beta signal, however, did not 
indicate a significant difference between the radiation types. 
 
Biological Aspects of Model Design 
Cell culture models have been essential in the understanding of radiation effects.  The 
research using these models has provided important data on intracellular pathways and 
bystander effects post irradiation.  However, these models do not integrate the 
contributions to radiation effects by extracellular matrix components.  Moreover, the 
cells in cellular in vitro models do not senesce.  While this makes it easier to culture the 
cell line, immortal cells are rarely seen in vivo and are thought to be limited to stem 
cells.  In an effort to mimic the in vivo environment, an ex vivo model for rat trachea was 
successfully developed. 
 
Gabridge and Hoglund as well as Marcus and Baker were the first to develop a perfusion 
chamber system for guinea pig trachea.  Their model was designed for studying bacterial 
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infection and was not adaptable for radiation experiments.  A design, based on the 
original perfusion chamber, was developed using commercially available coverglass 
wells, to allow radiation experiments to be conducted without significant shielding (see 
Fig. 5).    
 
After analysis of propidium iodide staining, physical damage to the epithelium, and 
PCNA antibody reaction, it was determined that the coverglass well perfusion chamber 
maintained the tracheal tissue in a healthy and viable condition for up to three days.  
Thus, irradiation experiments were performed within the first 24 hours and the trachea 
remained in the perfusion chamber less than 72 hours (see Fig. 10).   
 
The successful development of a perfusion chamber system, adapted for irradiation 
experiments, allowed for the introduction of numerous in vivo variables:  multiple cell 
types, cartilage rings, increased cell-cell signaling, growth factors, and nutritional needs.  
It is thought that these variables would cause a cell to respond more like an in vivo cell 
and provide a more direct correlation between in vitro and in vivo data (see Fig. 9 and 
Fig. 15).   
 
Radiological Aspects of Model Design 
Current radiation dose limits are based on the linear non-threshold extrapolation from 
high doses to zero.  Underlying the linear extrapolation argument is the assumption that 
a cell responds autonomously to low doses of radiation.  However, cells are stimulated to 
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divide, differentiate, or self destruct by neighboring cells and the extracellular matrix.  In 
addition, there are data suggesting that unirradiated cells in an irradiated population may 
alter their level of repair related proteins (65) and their DNA metabolism (22, 66, 67).  
Therefore, it is very likely that an irradiated cell does not act autonomously but is 
influenced by its environment.  
 
The gene expression of perfused rat trachea was examined to determine the effects of the 
perfusion chamber and radiation on the cells in the trachea.  It was found that the gene 
expression of perfused trachea was not significantly different compared to fresh trachea.  
There was an increase in genes associated with mucus secretion, but this may be a result 
of the media, used to hydrate and provide nutrition for the cells, flowing through the 
lumen.  In contrast, the 250 kVp x-ray irradiated trachea showed an eight-fold increase 
for CDKN1A expression.  CDKN1A functions as a regulator of cell cycle progression at 
G1 and can interact with PCNA.  Thus, the low dose of x-rays could be activating repair 
processes or arresting the cells.   
 
The gene expression array further supported the perfusion chamber model as a design for 
mimicking in vivo trachea.  However, further research into the effects of increased 
mucus production on the cell response to radiation needs to be investigated.  The gene 
expression array also showed a measurable response was found post low-doses of low-
LET radiation.  This measurement technique could be used in the future to better 
understand the response of a whole tissue to radiation in an ex vivo environment.   
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Comparative Effects of Low- and High-LET 
TGF-beta is an important signal transducer and is activated in response to injury.  Active 
TGF-beta is known to have three major roles in tissue: immunosuppression, deposition 
of extracellular matrix components, and cell growth inhibition.  The continual deposition 
of extracellular matrix components due to the activation of TGF-beta is a significant part 
of fibrosis of tissue.  This response has been proven in irradiated tissue and can be 
stopped or reduced by inactivating TGF-beta.  However, low-LET radiation is the only 
radiation type used to study TGF-beta activation.  A large gap in the published data 
exists for the TGF-beta response to high-LET radiation after TGF-beta inactivation.   
 
This research studied the effect of high-LET Fe ions on the overall TGF-beta response 
after TGF-beta inactivation and compared the results to the TGF-beta response post x-
ray irradiation.  It was found that a TGF-beta response could be measured in the tracheal 
tissue, for x-ray and Fe ion irradiations, despite the high autofluorescent background 
intrinsic to tissue.  However, after comparing the TGF-beta response of x-ray irradiation 
to HZE irradiation, there was not a significant difference in radiation types.  Clearly, this 
may be because the tissue TGF-beta responses to low doses of low- and high-LET 
radiation are similar, thus indicating the published fibrosis data using low-LET radiation 
describes the response that would be seen for high-LET.  However, the TGF-beta 
response could be masked by interfering signals intrinsic to a tissue with multiple cell 
types and increased cell signaling.   
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The TGF-beta response in x-ray and HZE irradiated perfusion chambers was also 
measured over time post irradiation.  It was found that for 6 hour and 8 hour post 
irradiation, the TGF-beta response was higher for lower doses of radiation than for 
higher doses.  This is in contrast to the 0 hour fixation which found the TGF-beta 
response to increase with increased dose.  The inverse relationship found for 6 hour and 
8 hour fixation times may indicate a threshold response for TGF-beta response; i.e., for 
low doses, a threshold of dose must be reached for an immediate TGF-beta response, or 
else the tissue responds more slowly to the irradiation damage.  These data may also 
indicated that the speed of cell response to radiation is determined by the initial dose.  
This result was unexpected and will require further investigation to determine if the 
threshold or speed of response can be determined for the 250 kVp x-rays and 1 Gev Fe 
ions.  
 
Future Work 
The work completed in this project established the perfusion chamber system as an ex 
vivo model for studying radiation effects in respiratory tissue.  It was determined that a 
measured difference in TGF-beta response could be detected between negative and 
positive controls.  However, the TGF-beta response could not be differentiated between 
x-ray and HZE experiments, and the inability to measure a difference may be due to 
insensitivity of the immunohistochemistry technique.  Therefore, to insure that the lack 
of difference between the two radiation types is not more than the limits of the 
measurement technique, more gene expression arrays should be completed.  This would 
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support the results found in this research (or show the limits of the measurement 
techniques).  In addition, more TGF-beta response experiments should be completed to 
determine if a threshold can be determined for its response.  The preliminary results 
indicate that a threshold may exist and gene expression arrays could help to clearly 
elucidate a threshold.      
 
The repopulation experiments attempted in this project were not a success; however, 
repopulation of xenografts has proven successful.  Xenografts are a step closer to in vivo 
but are limited in the number of variables (radiation type, nutrition, etc.) that can be 
introduced into the experiment.  It is believed that perfusion chamber trachea 
repopulated with human cells would provide excellent data to link human, animal, and 
cell research, and as more experiments into repopulating trachea as new techniques 
become available the research in this are should move forward. 
 
The establishment of an ex vivo model for radiation experiments with respiratory tissue 
opens the door for more research into correlating data between cell culture models and in 
vivo data.  While the perfusion chamber is not a perfect model for in vivo, it allows for 
more intricate experiments using intact tissue, including: microbeam irradiations using 
cell culture and perfusion chamber models.  The data would further support the previous 
work studying bystander effects and their role in creating a preneoplastic condition. 
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APPENDIX A 
PERFUSION CHAMBER PROTOCOLS 
1. Anaesthetize rats 6 hours prior to irradiation. 
2. Excise tracheas, hold on ice in separate 15 ml. tubes with 5 ml. of cold BNL1 (60 
ml.). 
3. For the next steps each trachea is treated separately through the entire procedure: 
a. Melt 3% sterile agarose in distilled water (enzyme free, Invitrogen)in 60C 
bath. 
b. Warm 2X BNL1 to 37C. 
c. Mix 6 ml. of agarose with 6 ml. of 2X BNL1 and lay down thin layer (2 
ml.) in each chamber.  Refrigerate briefly to set the gel. 
d. Dissect trachea to remove excess tissue and to yield 2 sections of roughly 
equal length. Retain excess pieces for histology. 
e. Mix 3 ml. of agarose with 3 ml. of 2X BNL1 (6 ml.). 
f. Place each section between two coverslips and pour an agarose overlayer.  
Refrigerate briefly to set the gel. 
g. Remove coverslips and clear lumen of any agarose using 1000 
micropipettor and sterile tip with medium. 
h. Remove excess agarose. 
i. Fill chamber with 2-3 ml. of 1X BNL1 and place in incubator on rocking 
platform. 
4. Repeat steps 3 a. through i. until all tissue samples are prepared. 
5. While steps 3 and 4 are being completed someone needs to go to the NSRL 
irradiation facililty and prepare the area for the run.  Check and clean surfaces, 
check incubators, and set up rocking platforms in incubator(s), As well as 
transport sample holders and fixative (cold MeOH:acetone (on ice)). 
6. Warm bottles of distilled water to 37C. 
7. Transport perfusion chambers in trays to NSRL irradiation facility 
8. Replace medium, if lost in transit.   
9. Hold perfusion chambers in incubator on rocking platform until irradiation. 
10. Irradiate two samples at a time, in axial or transverse orientation.  Perform sham 
irradiations mixed in with irradiations.  Record time, dose and orientation to the 
beam. 
11. Fix some samples immediately after irradiation with cold MeOH:Acetone for at 
least twenty minutes after rinsing with cold PBS in the chamber.  Switch to 70% 
Ethanol thereafter. 
12. Transfer the remainder of the samples to Medical division to hold in incubator. 
13. Replace medium, if lost in transit. 
14. Fix replicate samples at 4, 8 and 12 hour intervals with cold MeOH:acetone as 
above. 
15. Trim and transfer samples to histology cassettes for transport to TAMU. 
16. Ship samples and supplies to TAMU overnight. 
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APPENDIX B 
CHAMBER HOLDER FOR HZE IRRADIATIONS 
 
 
 
 
 
 
 
FIG. A-1.  The irradiation holder for all tracheas irradiated at Brookhaven National 
Laboratory’s HZE irradiation facility. 
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APPENDIX C 
DATA SPREADSHEET 
 
An electronic copy of the raw data used to generate the data and figures in this 
dissertation is available at the Thesis Office of Texas A&M University and at the 
following web address: https://lowdosedata.tamu.edu.  The files include a list of all 
trachea samples, the original fluorescent images, the total fluorescence yield, the 
fluorescent yield for bins 25-75, error analysis information, and the figures seen above.   
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